| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Chairman | Director
2 companies
Broshy Eran is a Director at TBPH, with reported holdings spanning 2 companies. Recent filings cover 2 purchases and 5 sales. Those positions are worth an estimated $1.2M at current prices.
Our model assigns Broshy Eran a below-average insider score of 31/100, based on 4 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -19.0%.
Broshy Eran's largest disclosed position is in TBPH as Director, worth about $1.2M. The recent filings there lean toward selling, a net 88,501 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | TBPH Theravance Biopharma, Inc. | Director | Sale+OE | 29,501 | $20.00 | $590,020.00 | -39.8% | -4.5% | - | |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Director | Sale+OE | 59,000 | $18.11 | $1,068,250.00 | -56.1% | +5.4% | - | |
| Aug 22, 2023 | CERT Certara, Inc. | Director | Buy | 5,000 | $15.81 | $79,057.90 | +53.4% | -6.1% | -17.7% |